Meihua International Medical Technologies Co., Ltd.
MHUA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.05 | 0.04 | -0.45 | 1.15 |
| FCF Yield | 153.54% | -6.80% | -6.12% | -0.30% |
| EV / EBITDA | 0.09 | 1.64 | 14.93 | 11.17 |
| Quality | ||||
| ROIC | 6.82% | 7.33% | 4.21% | 18.57% |
| Gross Margin | 34.36% | 34.08% | 36.86% | 38.26% |
| Cash Conversion Ratio | 1.35 | 0.20 | -1.48 | -0.00 |
| Growth | ||||
| Revenue 3-Year CAGR | -2.12% | -2.27% | 5.08% | 9.32% |
| Free Cash Flow Growth | 701.59% | 79.68% | -1,210.85% | 91.62% |
| Safety | ||||
| Net Debt / EBITDA | -0.51 | -0.61 | -1.71 | -0.11 |
| Interest Coverage | 9.50 | 58.52 | 55.49 | 145.29 |
| Efficiency | ||||
| Inventory Turnover | 45.12 | 39.58 | 58.15 | 51.33 |
| Cash Conversion Cycle | 352.42 | 292.95 | 237.74 | 191.29 |